globalacademycme.com
link.springer.com
The message of BeSt trial at 10 years:
It’s not what you start with (mono- or combo-therapy, steroid or biologic),
but how you keep to the straight and narrow (tight control with timely therapeutic adjustments to achieve and maintain low disease activity),
that gets you a good outcome ultimately (minimal damage or disability, good function and quality of life).
It’s not what you start with (mono- or combo-therapy, steroid or biologic),
but how you keep to the straight and narrow (tight control with timely therapeutic adjustments to achieve and maintain low disease activity),
that gets you a good outcome ultimately (minimal damage or disability, good function and quality of life).